Charles Schwab Investment Management Inc Landec Corp \Ca\ Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 74,427 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,427
Previous 60,505
23.01%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding LNDC
# of Institutions
75Shares Held
24.5MCall Options Held
31.5KPut Options Held
11.4K-
Wynnefield Capital Inc New York, NY4.7MShares$00.0% of portfolio
-
Legion Partners Asset Management, LLC Los Angeles, CA4.43MShares$00.0% of portfolio
-
Greenhaven Road Investment Management, L.P. Greenwich, CT3.62MShares$00.0% of portfolio
-
325 Capital LLC New York, NY2.16MShares$00.0% of portfolio
-
22 Nw, LP Seattle, WA1.76MShares$00.0% of portfolio
About LANDEC CORP \CA\
- Ticker LNDC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,595,600
- Description
- Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...